Coumarin Anticoagulants/Vitamin K-Containing Foods Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug, changing your diet or commencing any course of treatment.
Very important. A change in your diet, medicine, or dosage may be necessary. Promptly consult your doctor or pharmacist.
How the interaction occurs:
When your anticoagulant ("blood-thinner") is taken with foods containing vitamin K, the vitamin K may prevent your anticoagulant from effectively preventing blood clots.
What might happen:
The beneficial effects of your anticoagulant may decrease, which may increase your risk of an unwanted blood clot.
What you should do about this interaction:
Avoid sudden changes in your diet while you are taking this medicine. Foods high in Vitamin K are of the most concern, but the best approach is to try to be consistent in your daily food choices. Do not change the amount of moderate-to-high Vitamin K-containing food in your diet (see the lists below) without first consulting your healthcare professional (e.g., doctor or pharmacist).Also, do not use a strict vegetarian diet (some greens have moderate-to-high Vitamin K content) without first consulting your healthcare professional.Some examples of foods high or moderate in Vitamin K content are listed below: High Level Vitamin K Foods (micrograms per serving listed) include Kale, fresh (547.4 micrograms per 1 cup); Swiss Chard, fresh (298.8 micrograms per 1 cup); Broccoli, frozen, boiled (248.4 micrograms per 1/2 cup); Broccoli, fresh, boiled (210.6 micrograms per 1/2 cup); Spinach, fresh (120 micrograms per 1 cup); Green or Red Leaf Lettuce (117.6 micrograms per 1 cup); Escarole, fresh (115.5 micrograms per 1 cup); Endive, fresh (115.5 micrograms per 1 cup); Cabbage, fresh (101.5 micrograms per 1 cup); Moderate Level Vitamin K Foods (micrograms per serving listed) include Mustard Greens, fresh (95.2 micrograms per 1 cup); Brussels Sprouts, fresh (77.9 micrograms per 1/2 cup); Butterhead Lettuce (67.1 micrograms per 1 cup); Watercress (42.5 micrograms per 1/2 cup); Yellow Snap Beans (41.3 micrograms per 3/4 cup); Kiwi Fruit (38 micrograms per 2 items); Asparagus, fresh (35.7 micrograms per 2/3 cup); Soybeans, dry roasted (31.8 micrograms per 1/2 cup); Split Peas, boiled (27.5 micrograms per 1/2 cup); Green Peas (27.3 micrograms per 1/2 cup); Soybean Oil (26.2 micrograms per 1 tablespoonful); Abalone, Raw (26.1 micrograms per 1/2 cup); Green Beans, cooked (25.8 micrograms per 1/2 cup). Avocados, some varieties of seaweed, and liquid nutritional supplements also contain vitamin K.Contact your doctor or pharmacist for more information. Your healthcare professionals may be aware of this interaction and may be monitoring you for it. Do not start, stop, or change your medicine or diet before checking with them first.
- 1.BREST AN, BOWER R, HEIDER C. ANTICOAGULANT THERAPY--A CLINICAL DILEMMA. JAMA 1964 Feb 15;187:SUPPL 27-40.
- 2.Andersen P, Godal HC. Predictable reduction in anticoagulant activity of warfarin by small amounts of vitamin K. Acta Med Scand 1975 Oct; 198(4):269-70.
- 3.Qureshi GD, Reinders TP, Swint JJ, Slate MB. Acquired warfarin resistance and weight-reducing diet. Arch Intern Med 1981 Mar;141(4):507-9.
- 4.Kempin SJ. Warfarin resistance caused by broccoli. N Engl J Med 1983 May 19;308(20):1229-30.
- 5.Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand 1986;220(4):347-50.
- 6.Walker FB 4th. Myocardial infarction after diet-induced warfarin resistance. Arch Intern Med 1984 Oct;144(10):2089-90.
- 7.Martin JE, Lutomski DM. Warfarin resistance and enteral feedings. JPEN J Parenter Enteral Nutr 1989 Mar-Apr;13(2):206-8.
- 8.Suttie JW. Warfarin and vitamin K. Clin Cardiol 1990 Apr;13(4 Suppl 6):VI16-8.
- 9.Chow WH, Chow TC, Tse TM, Tai YT, Lee WT. Anticoagulation instability with life-threatening complication after dietary modification. Postgrad Med J 1990 Oct;66(780):855-7.
- 10.Pedersen FM, Hamberg O, Hess K, Ovesen L. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991 Jun;229(6):517-20.
- 11.Dickerson RN, Garmon WM, Kuhl DA, Minard G, Brown RO. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Pharmacotherapy 2008 Mar; 28(3):308-13.
- 12.Custodio das Dores SM, Booth SL, Martini LA, de Carvalho Gouvea VH, Padovani CR, de Abreu Maffei FH, Campana AO, Rupp de Paiva SA. Relationship between diet and anticoagulant response to warfarin: a factor analysis. Eur J Nutr 2007 Apr;46(3):147-54.
- 13.Ford SK, Misita CP, Shilliday BB, Malone RM, Moore CG, Moll S. Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios. J Thromb Thrombolysis 2007 Aug;24(1):23-7.
- 14.Kudo T. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery 1990;17(4):189-201.
- 15.Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007 Mar 15;109(6):2419-23.
- 16.Couris R, Tataronis G, McCloskey W, Oertel L, Dallal G, Dwyer J, Blumberg JB. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices. Int J Vitam Nutr Res 2006 Mar;76(2):65-74.
- 17.Cheng TO. Potential interaction between soy milk and warfarin. Am Fam Physician 2004 Oct 1;70(7):1231.
- 18.Zandijk E. A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding. Ned Tijdschr Geneeskd 2004 Sep 18; 148(38):1896.
- 19.van Iersel MD, Blenke AA, Kremer HP, Hekster YA. A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding. Ned Tijdschr Geneeskd 2004 Jun 5;148(23):1155-7.
- 20.Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004 May 15; 116(10):651-6.
- 21.Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, Kesteven P, Kamali F. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol 2004 Feb;124(3):348-54.
- 22.Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother 2002 Dec;36(12):1893-6.
- 23.Penrod LE, Allen JB, Cabacungan LR. Warfarin resistance and enteral feedings: 2 case reports and a supporting in vitro study. Arch Phys Med Rehabil 2001 Sep;82(9):1270-3.
- 24.Petretich DA. Reversal of osmolite-warfarin interaction by changing warfarin administration time. Clin Pharm 1990 Feb;9(2):93.
- 25.Homma K, Wakana N, Suzuki Y, Nukui M, Daimatsu T, Tanaka E, Tanaka K, Koga Y, Nakajima Y, Nakazawa H. Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin. J Nutr Sci Vitaminol (Tokyo) 2006 Oct; 52(5):297-301.
- 26.Oren B, Shvartzman P. Unsuspected source of vitamin K in patients treated with anticoagulants: a case report. Fam Pract 1989 Jun;6(2):151-2.
- 27.Ovesen L, Lyduch S, Idorn ML. The effect of a diet rich in brussels sprouts on warfarin pharmacokinetics. Eur J Clin Pharmacol 1988; 34(5):521-3.
- 28.Akrabawi SS. Warfarin and enteral nutrition products. J Am Diet Assoc 1986 Aug;86(8):1096.
- 29.Howard PA, Hannaman KN. Warfarin resistance linked to enteral nutrition products. J Am Diet Assoc 1985 Jun;85(6):713-5.
- 30.Zallman JA, Lee DP, Jeffrey PL. Liquid nutrition as a cause of warfarin resistance. Am J Hosp Pharm 1981 Aug;38(8):1174.
- 31.Lader E, Yang L, Clarke A. Warfarin dosage and vitamin K in Osmolite. Ann Intern Med 1980 Aug;93(2):373-4.
- 32.O'Reilly RA, Rytand DA. "Resistance" to warfarin due to unrecognized vitamin K supplementation. N Engl J Med 1980 Jul 17;303(3):160-1.
- 33.Michaelson R, Kempin SJ, Navia B, Gold JW. Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement. Clin Bull 1980;10(4):171-2.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.